Metastatic axillary lymph node from occult breast carcinoma: A case report

Metastatic axillary lymph node from occult breast carcinoma poses a difficult and challenging management. It is a rare entity accounting only 0.3-1% cases of all breast cancer. It involves a multidisciplinary discussion and collaboration. Traditionally the treatment consists of mastectomy with axill...

Full description

Bibliographic Details
Main Authors: Aripin, Y.M (Author), Rashid, N.F.A (Author)
Format: Article
Language:English
Published: Gazi Universitesi 2019
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus
LEADER 03512nam a2200541Ia 4500
001 10.12996-gmj.2019.49
008 220121s2019 CNT 000 0 und d
020 |a 21472092 (ISSN) 
245 1 0 |a Metastatic axillary lymph node from occult breast carcinoma: A case report 
260 0 |b Gazi Universitesi  |c 2019 
650 0 4 |a adjuvant chemotherapy 
650 0 4 |a adjuvant radiotherapy 
650 0 4 |a adult 
650 0 4 |a Article 
650 0 4 |a axillary lymph node 
650 0 4 |a breast carcinoma 
650 0 4 |a Breast conservation therapy (BCT) 
650 0 4 |a case report 
650 0 4 |a clinical article 
650 0 4 |a cytology 
650 0 4 |a echomammography 
650 0 4 |a excision 
650 0 4 |a family history 
650 0 4 |a female 
650 0 4 |a fine needle aspiration biopsy 
650 0 4 |a histopathology 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a lymph node biopsy 
650 0 4 |a lymph node dissection 
650 0 4 |a Lymph node dissection 
650 0 4 |a lymph node metastasis 
650 0 4 |a mammography 
650 0 4 |a mastectomy 
650 0 4 |a Mastectomy 
650 0 4 |a middle aged 
650 0 4 |a nuclear magnetic resonance imaging 
650 0 4 |a Occult breast cancer 
650 0 4 |a occult cancer 
650 0 4 |a positron emission tomography-computed tomography 
650 0 4 |a swelling 
650 0 4 |a trastuzumab 
856 |z View Fulltext in Publisher  |u https://doi.org/10.12996/gmj.2019.49 
856 |z View in Scopus  |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064404867&doi=10.12996%2fgmj.2019.49&partnerID=40&md5=e19aa476679a7f25b293add63575ba36 
520 3 |a Metastatic axillary lymph node from occult breast carcinoma poses a difficult and challenging management. It is a rare entity accounting only 0.3-1% cases of all breast cancer. It involves a multidisciplinary discussion and collaboration. Traditionally the treatment consists of mastectomy with axillary lymph node dissection however the practice patterns have steadily changed over the last two to three decades with an emphasized-on breast conservation therapy (BCT). Here we present a 58-year-old lady presented with enlarging right axilla swelling for one month without any breast lump or nipple discharge. Examination revealed 2 mobile right axilla lymph nodes with no palpable breast lump or demonstrable nipple discharge. Routine imaging including mammogram and ultrasound of the breast did not reveal any lesion except suspicious lymph nodes at the right axilla. Cytology of the lymph node showed suspicious of metastatic lesion. Magnetic resonance imaging of the breast also did not reveal any breast lesion. Positron emission tomography and computed tomography (PET CT) was done but did not show uptake to suggest primary lesion except uptake at the right axillary node and right internal mammary node. Excision biopsy of the right axillary node was proven to be metastatic carcinoma in keeping with breast as primary with negative for estrogen and progesterone receptor but c-erB2 positive. Mastectomy with axillary lymph node dissection was done and histopathology report was found to have 2x1 mm, grade 2 tumor in the breast. Patient underwent adjuvant chemotherapy and radiotherapy and currently on trastuzumab and is doing well with no signs of loco regional recurrence or distant metastasis. ©Copyright 2019 by Gazi University Medical Faculty 
700 1 0 |a Aripin, Y.M.  |e author  
700 1 0 |a Rashid, N.F.A.  |e author  
773 |t Gazi Medical Journal  |x 21472092 (ISSN)  |g 30 2, 199-201